"Cancer Treatment Centers of America® (CTCA), Atlanta, is a comprehensive cancer care and research center located a short drive from downtown Atlanta in Newnan, Georgia. CTCA® is dedicated to tailoring a combination of cancer treatments to the needs of each individual patient. Comprehensive cancer services, from advanced genomic testing to clinical trials and evidence-informed supportive therapies, are delivered by a team of experts, all under one roof. Our oncologists offer a level of expertise that comes from working with cancer patients every day to deliver personalized medicine using today's scientific advances. We treat patients with all types and stages of cancer, at any point in their journey. Cancer treatment is our specialty."

During the past decade, Cancer Treatment Centers of America conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 10 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 10 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Treatment Centers of America" #1 sponsor was "Celgene" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Galena Biopharma, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Astellas Pharma Global Development, Inc." with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Treatment Centers of America" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Treatment Centers of America" are "Breast Cancer" (4 trials), "Advanced Solid Tumor" (1 trials), "Advanced Squamous Non-Small Cell Lung Carcinoma" (1 trials), "Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors" (1 trials) and "Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers" (1 trials). Many other conditions were trialed in "Cancer Treatment Centers of America" in a lesser frequency.

Most popular intervention types in "Cancer Treatment Centers of America" are "Drug" (21 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (5 trials), "Capecitabine" (3 trials), "Paclitaxel" (3 trials), "Placebo" (3 trials) and "Nab-Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Treatment Centers of America" are 23 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cancer Treatment Centers of America". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Cancer Treatment Centers of America, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Treatment Centers of America, 5 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".